Kamil Ali-Jackson is an Independent Board Director for publicly traded life sciences companies and a life sciences entrepreneur and co-founder of several venture capital-funded life sciences companies. Ali-Jackson successfully exited her companies through multi-million-dollar acquisitions by global life sciences companies.
Ali-Jackson is a C-suite leader with extensive legal, business development, licensing, compliance, and human resources experience.
Ali-Jackson currently serves on the board of PDS Biotechnology Corporation as the Chair of the Nominating and Corporate Governance Committee and member of the audit and compensation committee and as an audit, compensation, and finance committee member for Rigel Pharmaceuticals, Inc.
Ali-Jackson is also an advisor for startups and lecturer in law at the University of Pennsylvania Carey Law School. She is also a trustee for Princeton University.
Ali-Jackson earned her A.B. in politics from Princeton and her J.D. from Harvard Law School.
